Related Experiment Video
Updated: Apr 16, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
Pre-eclampsia during pregnancy and cardiovascular disease later in life: the case for a risk group
1BioFact Environmental Health Research Centre, Björkåsvägen 21, 443 91, Lerum, Sweden, envhealth@biofact.se.
Introduction:
Women with pre-eclampsia (PE) have an increased risk of cardiovascular disease (CVD) later in life. This association might reflect an effect of pre-eclampsia on mechanisms inducing a higher risk of CVD or the presence of a group at risk.
Materials And Methods:
The possibility that women with a magnesium deficiency might constitute a risk group was examined using published evidence form investigations on PE and CVD.
Results:
Available data strongly suggest that a magnesium deficiency is a major risk factor for both PE and for CVD disease later in life.
Conclusions:
Magnesium homeostasis studies in women with PE should be undertaken for validation purposes. The results suggest that women with PE should be given dietary counselling to decrease future risks of CVD.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
Hormonal Regulation
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational

